The NF-κB pathway is well known as an inflammatory signaling pathway, and a recent article reported that the accumulation of the inflammatory factor high-mobility group box 1 (Hmgb1) in MCs exacerbated DKD progression by accelerating the activation of the NF-κB signaling pathway through binding to IκBα 76. Here, NFKB1 is linked to diabetic kidney disease.